Plasmodium falciparum sporozoite vaccines
Sanaria has made interesting progress with the development of the PfSPZ Vaccine that has the capacity to provide long-term protection as well as protection against diverse parasite strains. This has recently (2017) been published in 4 articles (see below). Read the announcement 'Progress with Sanaria’s Plasmodium falciparum sporozoite vaccines' here.
- JCI Insight: Epstein JE et al. Protection against Plasmodium falciparum malaria by PfSPZ Vaccine
- PNAS: Lyke K et al. Attenuated PfSPZ vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection
- Lancet Infectious Diseases: Sissoko MS, Healy SA, et al. Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed Malian adults: a randomised, double-blind trial
- Nature: Mordmüller B et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine
New job opportunity
The Wellcome Trust Sanger Institute has a position available for a Postdoc on single cell biology for malaria. Closing date for applications: 11th April 2017. Read the job announcement 'Postdoctoral Fellow - Single Cell Biology of Malaria' here.
Reminder 2 job opportunities
Please be reminded that the following 2 vacancies are still open for application:
- Postdoctoral Fellow - Malaria Genetics (Wellcome Trust Sanger Institute): deadline 5 April 2017
- Project Manager/Field Coordinator Malaria (New York University): deadline 15 May 2017
Enjoy this week's MalariaWorld - the MW team
Support MalariaWorld to provide Open Access to malaria information for all. We will use your donation solely to further develop MalariaWorld. MalariaWorld is a project of the Dutch Malaria Foundation, a charitable, registered, not-for-profit organisation. If you still have any questions then just contact us at email@example.com
MalariaWorld Journal (MWJ) is the only peer-reviewed Open Access journal on malaria where you don’t pay to publish, you don’t pay to read, and authors get paid € 150 for each published paper. Read about MW and how you can submit your manuscript here.
Log in at MalariaWorld. Remember that you have to log-in at MW to read more, respond to polls, open attachments and get free copies of books and other documents. Forgot your username and/or password? Go to www.malariaworld.org, click on Sign in and then on Request new password. Fill out your email address that you use to receive the MW newsletter and the Word verification. You will then receive further instructions by email.